Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional study
Authors:
- Jouni RanuaJRJouni Ranua
- Katja LuomaKLKatja Luoma
- Anssi AuvinenAAAnssi Auvinen
- Jukka PeltolaJPJukka Peltola
- Anna-Maija HaapalaAHAnna-Maija Haapala
- Jani RaitanenJRJani Raitanen
- Jouko IsojärviJIJouko Isojärvi
- 1 March 2005
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 6 (2) , 191-195
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Anticardiolipin and antinuclear antibodies in epilepsy—a population-based cross-sectional studyEpilepsy Research, 2004
- Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizuresJournal of Neuroimmunology, 2002
- The use of immunoglobulins in the treatment of human epilepsyNeurological Sciences, 2002
- High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 casesEpilepsy Research, 2001
- Epilepsy and the Immune SystemArchives of Neurology, 2000
- Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disordersThe American Journal of Medicine, 2000
- Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsyNeurology, 2000
- Prevalence and Signification of Antinuclear and Anticardiolipin Antibodies in Patients with EpilepsyThe American Journal of Medicine, 1997
- Immunological aspects of epilepsyBrain and Development, 1993
- Immunoglobulin Levels and Autoantibodies in Epileptics on Long‐term Anticonvulsant TherapyActa Medica Scandinavica, 1977